Share

April 18, 2017; 88 (16 Supplement) April 23, 2017

PRELIMINARY RESULTS OF THE PHASE I CLINICAL STUDY EVALUATING NEURAL STEM CELL BASED THERAPY FOR PARKINSON’S DISEASE (S4.004)

Russell Kern, Ibon Garitaonandia, Rodolfo Gonzalez, Glenn Sherman, Andrey Semechkin, Evan Snyder, Azmin Shahrul, Girish Nair, Andrew Evans
First published April 17, 2017,
Citation
Permissions

Make Comment

See Comments

Downloads
0

Share

Article Information

vol. 88 no. 16 Supplement S4.004
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published April 17, 2017.
Copyright & Usage: 
© 2017

Author Disclosures

    1. Russell Kern1,
    2. Ibon Garitaonandia1,
    3. Rodolfo Gonzalez1,
    4. Glenn Sherman1,
    5. Andrey Semechkin1,
    6. Evan Snyder2,
    7. Azmin Shahrul3,4,
    8. Girish Nair3 and
    9. Andrew Evans3
  1. Russell Kern1,
  2. Ibon Garitaonandia1,
  3. Rodolfo Gonzalez1,
  4. Glenn Sherman1,
  5. Andrey Semechkin1,
  6. Evan Snyder2,
  7. Azmin Shahrul3,4,
  8. Girish Nair3 and
  9. Andrew Evans3
  1. 1International Stem Cell Corporation Carlsbad CA United States
  2. 2Sanford-Burnham-Prebys Medical Discovery Institute La Jolla CA United States
  3. 3The Royal Melbourne Hospital Parkville Australia
  4. 4Department of Medicine, UKM Medical Centre Parkville Australia

Article usage

Article usage: April 2017 to April 2023

AbstractFullPdfSource
Apr 20173000Highwire
May 201712200Highwire
Jun 20174800Highwire
Jul 20172600Highwire
Aug 201725200Highwire
Sep 201713300Highwire
Oct 20177000Highwire
Nov 20177500Highwire
Dec 20175300Highwire
Jan 20185500Highwire
Feb 20182600Highwire
Mar 20183500Highwire
Apr 20183400Highwire
May 20188800Highwire
Jun 20181700Highwire
Jul 20182400Highwire
Aug 20181100Highwire
Sep 20181500Highwire
Oct 20181200Highwire
Nov 20181700Highwire
Dec 20181100Highwire
Jan 20191100Highwire
Feb 20191400Highwire
Mar 20191900Highwire
Apr 20191000Highwire
May 20192300Highwire
Jun 2019800Highwire
Jul 20192200Highwire
Aug 20191100Highwire
Sep 20191600Highwire
Oct 2019600Highwire
Nov 20191400Highwire
Dec 2019300Highwire
Jan 2020800Highwire
Feb 20201200Highwire
Mar 2020700Highwire
Apr 2020700Highwire
May 20201100Highwire
Jun 2020600Highwire
Jul 2020500Highwire
Aug 2020400Highwire
Sep 2020400Highwire
Oct 2020500Highwire
Nov 2020700Highwire
Dec 20201000Highwire
Jan 2021500Highwire
Feb 2021300Highwire
Mar 2021600Highwire
Apr 2021600Highwire
May 2021400Highwire
Jun 2021300Highwire
Jul 20211700Highwire
Aug 2021500Highwire
Sep 2021700Highwire
Oct 2021200Highwire
Nov 2021400Highwire
Dec 2021300Highwire
Jan 2022900Highwire
Feb 2022600Highwire
Mar 2022400Highwire
Apr 2022900Highwire
May 2022600Highwire
Jun 2022100Highwire
Jul 20221300Highwire
Aug 2022600Highwire
Sep 2022400Highwire
Nov 2022600Highwire
Dec 2022500Highwire
Jan 2023300Highwire
Feb 2023400Highwire
Mar 2023500Highwire
Apr 2023300Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me